Divis Laboratories Ltd | DIVI - Umsatzkosten





Umsatzkosten Veränderung Datum
Alaunos Therapeutics USD 0 18K 2024-09
Aurobindo Pharma INR 36.27B 2.81B 2026-06
Avita Medical AUD 3.3M 166K 2025-12
Divis Laboratories Ltd INR 11.19B 1.2B 2026-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
IQVIA Holdings USD 3.22B 141M 2026-06
Lupin INR 25.42B 2.44B 2026-06
Moderna USD 93M 862M 2026-06
Organon & Co USD 711M 34M 2026-06
Revvity USD 312.82M 10.64M 2026-06
Tilray USD 164.37M 8.41M 2025-09
Viatris USD 2.3B 59.5M 2026-06
Xeris Pharmaceuticals USD 10.57M 3.08M 2026-03